M. Foster Olive is an assistant professor in the Psychology Department at Arizona State University, Tempe, Arizona.
He has received a PhD in Neuroscience from the University of California at Los Angeles, 1992-1997.
He has completed his B.A in Psychology from the University of California at San Diego (1991).
He has received a Hatos Scholarship from the Opioid Research Center at the University of California at Los Angeles, a Dean’s Postdoctoral Fellowship from the C.F. Aaron Endowment Fund in the School of Medicine at Stanford University, and has been elected to American College of Neuropsychopharmacology as an Associate Member.
He is serving as an editorial board member of several reputed journals, has been an ad hoc reviewer for over 40 neuroscience and psychology journals, and has authored 8 books, 10 invited review articles, and over 40 original research publications.
 

Behavioral Pharmacology
Behavioral Neuroscience
Drug Addiction
Alcoholism
Mental Disorders
Psychopharmacology
 

Kirk J. Brower
Professor of Psychiatry
University of Michigan East Medical Campus
Rachel Upjohn Building
Ann Arbor, Michigan, USA

Addiction Psychiatry

Prof. Ryabinin  has received his PhD in the P.K. Anokhin Institute of Normal Physiology, Moscow, Russia in June 1991, and did his postdoctoral training at the Scripps Research Institute, La Jola, California in 1991-1996. Currently,  he is working as a Professor of Behavioral Neuroscience in Oregon Health & Science University, Portland, Oregon. He is serving as an editorial member of Brain Research and refereed manuscripts for over forty scientific journals. He is member of the Society for Neuroscience, Research Society on Alcoholism, International Biomedical Research Society on Alcoholism, Society for the Study of Addictions and Society for the Advancement of Chicanos and Native Americans in Science.

Dr. Ryabinin’s main research interest is in the role of corticotropin releasing factor (CRF)-related peptides in alcohol and drug addiction. Besides CRF, these peptides include urocortin, urocortin 2 and urocortin 3. His laboratory applies a combination of molecular, genetic and neuroanatomical techniques to understand the behavioral role of these peptides. For example, his studies mapping expression of inducible transcription factors c-Fos, FosB and Zif268 in rodent brain identified that alcohol self-administration leads to selective changes of neural activity in the urocortin-positive - cells of the perioculomotor area (pIIIu, also known as the Edinger-Westphal nucleus). His further studies showed that these cells are not only extremely sensitive to alcohol but are involved in regulation of alcohol consumption.  For instance, using several inbred and selectively bred strains of mice and rats he found that alcohol-preferring strains of rodents have significantly higher measures of urocortin in the pIIIu and its projection areas than alcohol-avoiding strains. Furthermore, he showed that electrolytic lesions of urocortin-positive neurons completely eliminate alcohol preference in alcohol-preferring mice and attenuate alcohol-induced hypothermia. Another interest in his lab is developing novel animal models to study the contribution of social factors to alcohol and drug addiction

 

Dr Bernard Le Foll, MD PhD CCFP is a clinician-scientist specialized in drug addiction. He is Head of the Translational Addiction Research Laboratory at the Centre for Addiction and Mental Health and Associate Professor at University of Toronto in the Departments of Family and Community Medicine, Pharmacology, Psychiatry and Institute of Medical Sciences. Its clinical activity is centered on drug dependence. He received specialized training in drug addiction and behavioral and cognitive therapy. He has written clinical guidelines and has been coordinator of clinical trials. He obtained a PhD in Pharmacology at INSERM and has performed a Fogarty Visiting Fellowship at the NIH.

Novel therapeutic approaches using preclinical, clinical, genetic and brain imaging approaches. He has received scientific prizes and awards from the French Academy of Medicine, ACNP, CPDD, NIH, SRNT, CIHR and NARSAD.

Richard De La Garza,  Ph.D, is Associate Professor, Baylor College of Medicine, Menninger Department of Psychiatry and Behavioral Sciences, Department of Neuroscience, and Department of Pharmacology, Research Director and Associate Professor, University of Texas M.D. Anderson Cancer Center, Department of Psychiatry, and Department of Behavioral Science, Associate Professor, Michael E. DeBakey Veterans Affairs Medical Center, Research Services Line, Adjunct Associate Professor, University of Texas Medical Branch, Department of Pharmacology & Toxicology. He received a Ph.D. in neuroscience from the University of Texas Medical Branch, Galveston, TX 1991- 1996. He received a M.S. in biology from the University of North Texas, Denton, TX 1986-1989. He received a B.S. in biology from Texas A&M University-Commerce, Commerce, TX 1981-1985. He has received numerous awards including being named a Kavli Fellow of the National Academy of Sciences, and being named a Distinguished Alumnus of Texas A&M University-Commerce. He serves as an ad-hoc reviewer for more than a dozen high impact, peer-reviewed journals and is an elected member of the NIH Scientific Review Panel - Mechanisms of Emotion Stress and Health (MESH).

Medications testing for cocaine, methamphetamine and nicotine addiction. Use of virtual reality for cue-induced craving.Use of functional magnetic resonance imaging to identify neural substrates of reward processing in stimulant-addicted participants.

Rémi MARTIN-FARDON is a Staff Scientist in the Molecular and Integrative Neurosciences Department of The Scripps Research Institute, La Jolla. He received his Ph.D. in Biochemistry and Molecular Biology at The University of Montpellier II (France) in 1996. He completed his B.S. in biology and physiology at the University of Montpellier II (France) in 1989. He received his M.S. in physiology and pharmacology at the University of Montpellier II (France) in 1990. He is the member of 7 professional organizations that include the American Society for Pharmacology and Experimental Therapeutics (ASPET), the Research Society on Alcoholism (RSoA) and the College on Problems of Drug Dependence (CPDD). He is serving as a reviewer for 13 international journals that include Pharmacology Biochemistry and Behavior, The Journal of Pharmacology and Experimental Therapeutics, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Journal of Neuroscience, Behavioral Neuroscience, European Neuropsychopharmacology, The International Journal of Neuropsychopharmacology, Journal of Psychopharmacology.

Identification of new pharmacological targets for the prevention of relapse. Neurobiological basis of chronic vulnerability to relapse, with an emphasis on identifying neural substrates responsible for the distinctly compulsive nature of cocaine seeking, as compared to behavior motivated by natural rewards. Elucidating the selective role of various brain targets such as Group II metabotropic glutamate receptors, ?1 receptors, and the orexin/hypocretin system on drug-seeking.

Dennis M. Donovan is Director of the Alcohol and Drug Abuse Institute, University of Washington, Professor, Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Adjunct Professor, Department of Psychology, University of Washington.
He has received a PhD in Clinical Psychology from the University of Washington, 1980.
He is a Fellow in Divisions 50 (Addictions) and 28 (Psychopharmacology and Substance Abuse) of the American Psychological Association
Past President of the Society of Psychologists in Addictive Behaviors (precursor to APA Division 50)
He has served as an editorial board member of a number of addiction-related journals.
He has published over 150 articles, 33 book chapters, and 5 edited books.
He has had grants from the National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism, and the National Center on Minority Health and Health Disparities.

 

Alcoholism, drug dependence, and addictive behaviors
Social learning theory and cognitive-behavioral approaches to etiology, maintenance, and treatment
Treatment entrance and engagement
Evaluation of treatment process and outcome
Relapse prevention and maintenance of behavior change
Patient-treatment matching
Combined pharmacological and behavioral interventions for alcohol and drug dependence
Community-based participatory research
American Indian/Alaska Native substance abuse prevention, treatment and recovery
Cultural adaptation of prevention and treatment interventions
Dissemination of evidence-based practices
 

Roger Lee Papke
Professor
Department of pharmacology and therapeutics
University of florida School of Medicine
Gainesville, Florida 32610, USA

Steven L. Jaffe, MD has been a pioneer in the development of treatment programs for substance abusing adolescents and young adults & nbsp; He did his undergraduate studies at the Johns Hopkins University and attended medical school at the Albert Einstein College of Medicine. He completed a pediatric internship at UCLA and & nbsp; a psychiatric residency at the Mass. Mental Health Center where he was a teaching fellow at Harvard Medical School. A child and adolescent psychiatry fellowship was completed at Emory University.
           Presently, Dr. Jaffe is Professor Emeritus of Psychiatry at Emory University and Clinical Professor of Psychiatry at Morehouse School of Medicine. Dr. Jaffe consults to three adolescent young adult substance abuse programs: Atlana Insight Enthusiastic Sobriety Program, the Nelson Price Adolescent Substance Abuse Program & nbsp; and Recovery Outfitters. In addition he is a psychiatric consultant to the National Football League. He received the Presidents Award from Community Psychiatric Centers, Teaching Award from the Georgia Council of Child and Adolescent Psychiatry and was named Psychiatrist of the Year" by the Georgia Psychiatric Physicians Association.
            Dr. Jaffe has authored numerous papers and book chapters including the adolescent substance abuse chapters in the textbooks of child and adolescent psychiatry and the adolescent treatment chapter in the ASAM Textbook. Dr. Jaffes two wookbooks structure treatment for substance abusing teens. The Step Workbook for Adolescent Chemical Dependency: A Guide to the First Five Steps integrates psychiatric issues with 12-Step programs modified for adolescents. The Adolescent Substance Abuse Intervention Workbook: Working a First Step uses motivational interviewing principles to look at negative consequences of drug use. Dr. Jaffe has been Visiting Addiction Professor at the University of Hawaii and has given lectures and workshops throughout the United States, Australia and New Zealand.
 

Harry L. June
Professor of Psychiatry
Director of Substance Abuse
University of Maryland School of Medicine
Baltimore, Maryland 21201, USA

Damaris J. Rohsenow
Professor
Associate Director
Center for Alcohol and Addiction Studies
Brown University
Providence, RI 02912, USA

Prof. John A. Dani received his PhD in Physiology from the University of Minnesota and did postdoctoral training at the University of Washington and UCLA before becoming a Research Associate Scientist at Yale University. He is presently a Professor of Neuroscience at Baylor College of Medicine, where he also is Director of the Center for Learning and Memory. He has directed a Program Project Grant analyzing genetically engineered mice with alterations in their nicotinic receptors, and he currently studies addiction, learning, memory and related dysfunctions. He has served on 6 editorial boards, authored over 100 articles or book chapters, and is a member of several societies including the Society of General Physiologists, the Society for Neuroscience, and the Society for Research on Nicotine and Tobacco. He has been honored with a number of awards, including the DeBakey Award for outstanding research and the Jacob Javits Neuroscience Award from the National Institutes of Health.

Dr. Dani’s research focuses on fundamental mechanisms underlying the communication and adaptability of the nervous system. The studies have shown that drug addiction shares many commonalities with processes normally attributed to learning and memory. Drug addiction subverts normal mechanisms of neuronal adaptation, learning, and memory. That subversion leads to long-lasting changes in behavior that accrue with the ongoing progression toward addiction. A multidisciplinary approach using cellular and higher-level physiological and biophysical techniques are employed along with a powerful arsenal of in vivo recordings techniques to examine freely-moving rats and mice while they perform pertinent behavioral tasks. Recent effort have measured synaptic changes in the brains of freely moving mice in real time during drug-linked associative memory. The studied showed that dopamine signals enable and regulate the mechanisms of learning that link environmental cues to addictive drug use. In that way, these learning cues motivate continued drug use.

Dr. Janet Neisewander has received her PhD in Psychology at the University of Kentucky in 1988 and received post-doctoral training in Pharmacology and Psychiatry at the University for Pennsylvania during the period of 1988-1991. Currently, she is working as a Professor in the School of Life Sciences at Arizona State University. She has successfully completed administrative responsibilities as the founding Director of the Behavioral Neuroscience Program in Psychology at Arizona State University (2002-2006) and she has served on numerous grant review panels for NIH. She currently serves on the Program Committee for the College on Problems of Drug Dependence. She is serving as an editorial member of several reputed journals like Psychopharmacology and the International Journal of Neuropsychopharmacology. She has authored over 90 research articles and book chapters. She is a member of the American College of Neuropsychopharmacology, the College on Problems of Drug Dependence, the Society for Neuroscience, Women in Neuroscience, the International Behavioral Neuroscience Society, and the Behavioral Pharmacological Society.

Dr. Neisewander’s research investigates the neural mechanisms that are involved in drug dependence. Her particular interests include the neuroanatomical and neurotransmitter systems involved in modulating cocaine and nicotine self-administration and motivation for drug, including molecular changes that occur within the systems and how these changes can be countered using behavioral, pharmacological, and genetic approaches.  She is also interested in the influence of drug-conditioned effects and social factors on drug reward and dependence.
 

Robin Kanarek received her B.A. in biology from Antioch College, and M.S. and Ph.D. in psychology from Rutgers University. Following graduate school, she was a post-doctoral fellow in the Department of Nutrition at Harvard University, and a research fellow in the Division of Endocrinology at the University of California, Los Angeles. She came to Tufts as a research assistant professor, and then climbed the tenure ladder to become a full professor in the Psychology Department and at the Friedman School of Nutrition

Biological Psychology
Cognitive Psychology
Cognitive Neuroscience
Developmental Psychology
Experimental Clinical Psychology
Social Psychology

Professor Horace Loh received his PhD in biochemistry from the University of Iowa in 1965. Currently he is Regents Professor, Frederick Stark Professor, and Chair of the Department of Pharmacology, University of Minnesota. He serves as an associate editor of Annual Review of Pharmacology and Toxicology and of Current Opinion in Pharmacology. He has over 590 publications. His professional associations include membership in the American College of Neuropsychopharmacology, Society of Chinese Bioscientists in America, College on Problems of Drug Dependence, American Society of Pharmacology and Experimental Therapeutics, and Western Pharmacology Society. Dr. Loh has been recognized by the University of Minnesota as a Regents Professor, the first recipient of the Medical School’s Distinguished Senior Scientist Award, and one of the first inductees into the Academic Health Center’s Academy of Excellence. Other honors include the University of Iowa Carver College of Medicine’s Distinguished Alumnus Award; Nathan B. Eddy Memorial Award, College on Problems of Drug Dependence; Otto Krayer Award in Pharmacology, American Society for Pharmacology and Experimental Therapeutics; Award in Excellence, Pharmaceutical Research and Manufacturers of America Foundation; and Method to Extend Research in Time Award, Research Scientist Award, and Career Development Award, from the National Institutes of Health.

Dr. Horace H. Loh research interests are in the areas of molecular neuropharmacology and biochemical pharmacology, mainly specializing in the mechanism of narcotic actions and mechanism of tolerance. His detailed studies are in opioid receptor signaling, regulation of receptor activity, receptor gene cloning and receptor gene regulation and the pharmacology of endorphins. During the last decade of research, his research focuses have been on the protein kinases involved in regulating opioid receptor activities and on the transcription regulation of the opioid receptor genes.

Professor
School of Public Health
Syrian Center for Tobacco Studies
University of Memphis
TN 38152, USA

Smoking in developing countries, Waterpipe (hookah, shisha) smoking, Tobacco addiction, Epidemiology of tobacco use methods

Dr. Peter Martin has been a member of the faculty since 1986. He is Director of the Division of Addiction Psychiatry, Addiction Psychiatry Interdisciplinary Research Training Program and the Vanderbilt Addiction Center.  His research and scholarly interests include the molecular basis, diagnosis, and treatment of drug use disorders with an emphasis on substance-induced mental disorders
 

Molecular biology of thiamine, neuroimaging to elucidate the pathogenesis of addiction and alcohol-induced brain damage, and the clinical pharmacology of addictive substances, including novel pharmacological treatments of addictive disorders.
 

Professor Pharmacology
School of Medicine and Public Health
University of Wisconsin
Madison, USA
 

Membrane Excitability and Synaptic Transmission, Molecular Neuroscience, Neurobiology of Disease
 

Gregg E. Homanics
Professor
University of Pittsburgh School of Medicine
Pittsburgh
PA 15012, USA

Thomas E. Nordahl
Professor
Psychiatry and Behavioral Sciences
U.C. Davis Medical Center, USA

Neal Krause
Professor
Department of Health Behavior and Health Education
University of Michigan
Ann Arbor, MI 48109-2029, USA

Matthew Owen Howard
Professor
University of North Carolina at Chapel Hill
Chapel Hill, NC, USA

Thomas E. Malloy
Professor
Department of Psychology
Rhode Island College
Providence, Rhode Island, USA

K. Mark Derby
Professor
Department of Special Education
Gonzaga University
Spokane, Washington, USA

Wenyaw Chan
Professor
School of Public Health
University of Texas Health Science Center at Houston
Houston, TX 77030, USA

Dr. Michael J. Zvolensky is Richard and Pamela Ader Green and Gold Full Professor in the Department of Psychology at The University of Vermont (UVM) and Director of the Anxiety and Health Research Laboratory and Clinic. Dr. Zvolensky’s research program cuts across basic and applied work in the area of anxiety disorders. Specifically, his work is principally focused on examining vulnerability processes involved with the onset and maintenance of these disorders. He has been especially involved in better understanding the role of cigarette smoking in terms of the etiology and maintenance of panic psychopathology, and at the same time, the role panic vulnerability factors may play in smoking cessation. This work has broadly informed the study of the co-occurrence of anxiety and addictive disorders.
Dr. Zvolensky has published over 280 scientific articles (of these works, 250 are peer-review journal articles) and received a variety of contribution to the field awards from professional organizations. His research has been continuously funded by the National Institues of Health (NIH) since arriving to UVM in 2001. Dr. Zvolensky is currently Associated Editor for Cognitive Therapy and Research and Cognitive Behaviour Therapy. He sits on numerous editoral boards for other journals (e.g., Behavior Therapy), has served as guest editor for five different journals (e.g., Clinical Psychology Review, Addictive Behaviors),  and is a frequent grant reviewer for national and international organizations. In total, he has reviewed for over 50 journals and 7 distinct funding agencies. Outside of these professional activities, Dr. Zvolensky was previously the Chair of the Institutional Review Board at UVM and has been a comittee member on numerous commitee organizations in the Unites States of America addressing substance use problems among the mentally ill, including the NIH consensus report on mental illness and tobacco.
 

Although Dr. Zvolensky′s primary research interest is in the etiology and maintenance of tobacco-anxiety, he also has a significant track record in the areas of marijuana and emotional functioning and mechainisms underlying stress and medical illness associations.

Dr. Stein is Professor of Psychology at the University of RI (URI) and part of the Cancer Prevention Research Center (CPRC) within the Social Sciences Research Center (SSRC) of URI. The SSRC and CPRC are dedicated to studying behavior change as it relates to reducing health risks and enhancing health. She is also Adjunct Faculty within the Dept of Psychiatry and Human Behavior of Brown University and is a member of the training faculty at Brown’s Center for Alcohol and Addiction Studies (CAAS). Prior to URI, Dr. Stein was faculty at CAAS for 8 years, where she served on the selection/training committees for the Center’s NIAAA and NIDA research fellowships.  She founded and directed Brown University’s Juvenile Forensic Psychology Post-Doctoral Training Program. Publications include detection of under-reported substance abuse in juvenile correctional facilities, methods for enhancing treatment engagement during incarceration, family treatment for incarcerated juveniles, and reduction of at-risk behaviors after release.

Dr. Stein studies treatment and assessment of risky behaviors in persons involved in the justice system.  She also studies matters related to ethnic/racial bias in assessment and treatment. Dr. Stein is a licensed clinical psychologist and is Principal Investigator or Co-Investigator on several NIDA/NIAAA-funded grants studying assessment and treatment of incarcerated adults and adolescents. Targeted phenomena in these grants include group processes, reduction of substance use and risky sexual behavior, motivation to change, and more.

Chang-Guo Zhan is Professor of Pharmaceutical Sciences in the College of Pharmacy, University of Kentucky. Dr. Zhan received a Ph.D. in Chemistry from University of Notre Dame and a Ph.D. in Science from Institute for Molecular Science (IMS), Japan. Dr. Zhan performed his postdoctoral research training as a Postdoctoral Research Scientist at Department of Medicine, Columbia University. Dr. Zhan joined the UK College of Pharmacy faculty as Associate Professor in July 2003 and was promoted to Professor in July 2007. Dr. Zhan was elected as Fellow of the American Association of Pharmaceutical Scientists (AAPS) in 2010. Dr. Zhan is a winner of 2005 Emerging Computational Technology Prize, American Chemical Society (ACS) Division of Computers in Chemistry. He has served as Chair of AAPS Computational Drug Design Focus Group and on AAPS National Biotechnology Conference Programming Committee.

Li-Tzy Wu
Professor
Department of Psychiatry
Duke University Medical Center
Durham, North Carolina, USA

Lisa M. Najavits, PhD, is Professor of Psychiatry, Boston University School of Medicine; Lecturer, Harvard Medical School; clinical psychologist at VA Boston; and clinical associate, McLean Hospital. She is author of the books Seeking Safety: A Treatment Manual for PTSD and Substance Abuse (2002) and A Woman′s  Addiction Workbook (New Harbinger Press; 2002), as well as over 135 professional publications. She has received various awards, including the 1997 Young Professional Award of the International Society for Traumatic Stress Studies; the 1998 Early Career Contribution Award of the Society for Psychotherapy Research; the 2004 Emerging Leadership Award of the American Psychological Association Committee on Women; and the 2009 Betty Ford Award of the Addiction Medical Education and Research Association. She is currently past-president of the American Psychological Association Division on Addictions; and on the advisory boards of Psychotherapy Research, the Journal of Gambling Studies, and Addiction Research and Theory. Dr. Najavits has received a variety of National Institutes of Health and other research grants. She is a fellow of the American Psychological Association; board certified in behavioral therapy; a licensed psychologist in Massachusetts; a psychotherapy supervisor; and conducts a psychotherapy practice. She received her PhD in clinical psychology from Vanderbilt University (Nashville, Tennessee) and her bachelors degree with honors from Columbia University (New York, New York).

Her major clinical and research interests address vulnerable populations, including homeless, women, veterans, and community-based care; she specializes on trauma/substance abuse, development of new psychotherapies, and evaluation and outcome research.

Nick Heather
Professor
Department of Psychology
Northumbria University
NE1 8ST, UK

Tims is a general practitioner and a Professor in Primary Care at the University of Nottingham.  His research is mostly in the field of smoking cessation in primary care and in pregnancy, including the role of nicotine replacement therapy; he also researches ways of preventing relapse to smoking after cessation attempts have been initiated. He is a member of UK Centre for Tobacco Control Studies, working closely with Nottingham colleagues from the Division of Epidemiology and Public Health and other UK-based smoking cessation researchers.  He is also a member of the NIHR School for Primary Care research. Examples of work are:
• Smoking, Nicotine and Pregnancy (SNAP)Trial : the worlds largest trial of nicotine replacement therapy in pregnancy which has recruited 1050 women
• Proactive or Reactive Support for Smoking Cessation (PORTSSS): a recently completed a trial with 2591 participants testing offers of proactive support or NRT made via the NHS smoking helpline
• NIHR HTA monograph showing relapse prevention treatments to be effective and cost effective

 

Peter Hajek
Professor of Clinical Psychology
Director Tobacco Dependence Research Unit
University of London, UK

Xiangning Chen
Associate professor
Virginia Commonwealth University
Richmond, Virginia, USA

Haim Einat
Associate Professor
College of Pharmacy
University of Minnesota, USA

Tracy L.Simpson, PhD has over 20 years of research and clinical experience on trauma, mental health and co-occurring substance use outcomes. She received her Ph.D. in clinical psychology at University of New Mexico in 1999 under the mentorship of William Miller. In 2000, she completed a post-doctoral fellowship at the University of Washington under the mentorship of Alan Marlatt. Through her research at the VA Puget Sound Health Care System (VAPSHCS) and University of Washington she has refined a daily Interactive Voice Response (IVR) monitoring assessment protocol for use with individuals seeking treatment for an AUD, which she has successfully used in several treatment trials for alcohol dependence (AD). She currently is completing an NIAAA-funded R21 on mechanisms of change associated with brief behavioral interventions for individuals with PTSD and AD, and has two NIAAA-funded clinical trials underway evaluating the use of prazosin for AD with and without comorbid PTSD. 

Frequent monitoring; mechanisms of change; pharmacologic interventions for AD; comorbid disorders; women; veterans; mindfulness and meditation.

Jennifer Kim Plybon Penberthy, is an Associate Professor of Psychiatry in Department of Psychiatry & Neurobehavioral Sciences at University of Virginia School of Medicine, Charlottesville, VA, Director of Training and Chief, Center for Addiction Research and Education, Division of Neurobiology, Masters degree in Experimental Psychology from Wake Forest University, Winston-Salem, NC in 1992. PhD in Clinical Psychology from Virginia Commonwealth University, Richmond VA in 1998. Fellowship in Medical Psychology from University of Virginia SOM, Charlottesville, VA 2000. Winner of the Funding Excellence in Science and Technology Award at UVA 2002. Elected to the Academy of Distinguished Educators at UVA SOM 2006. Serving as an editorial board member of reputed journals and reviewer in multiple journals.

Development of effective behavioral treatments that are individualized based upon environmental and behavioral characteristics. Assessment of mechanisms of action of behavioral treatments for psychiatric disorders and addictions

Kevin M. Gray, M.D., is a board certified child, adolescent and adult psychiatrist.  He is Associate Professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina (MUSC) in Charleston, South Carolina.  Dr. Gray earned a B.S. in chemical engineering from Clemson University in 1996.  He then completed medical school, psychiatry residency, and child and adolescent psychiatry fellowship at MUSC before joining the faculty in 2005. Dr. Gray conducts National Institutes of Health sponsored clinical research on substance use disorders in adolescents and adults, with particular emphasis on cannabis and nicotine dependence. With a multidisciplinary group of collaborators at MUSC

Dr. Gray investigates biobehavioral mechanisms underlying substance use disorders, and works to apply these findings to treatment development

Laura M. Crothers
Associate Professor
Department of Counseling Psychology, and Special Education
Duquesne University
Pittsburgh, PA 15282, USA

Dr. Frank M. Orson received his M.D. from Baylor College of Medicine in 1977. After Fellowship training at the National Institutes of Health, he returned to Baylor to join the faculty in the Department of Medicine with joint appointments in Immunology and Molecular Virology.  Currently, he holds the position of Associate Professor of Medicine, and is Chief of Allergy/Immunology at the Veterans Affairs Medical Center in Houston. He has authored more than 50 research articles/books. He is a member of the American Association of Immunologists, the American College of Physicians, and the Southern Society for Clinical Research.

Dr. Orson’s current research involves the optimization of the design and composition of vaccines, as well as the study of adjuvants and other immunoregulatory molecules for vaccines to enhance immune responses to the target antigens. Among these targets, vaccines for drugs involved substance abuse, such as cocaine, methamphetamine, and heroin/morphine are being studied in ongoing projects.

Rajesh R. Tampi
Associate Professor
Psychiatry
Yale University School of Medicine
New Haven, CT, USA

Associate Professor
Psychiatry and Behavioral Sciences
Duke University
Durham, NC 27704, USA

Addiction Psychiatry

Shafiqur Rahman
Associate Professor
Department of Pharmaceutical Sciences
South Dakota State University
Brookings, SD 57007, USA

Cynthia L. Arfken
Associate Professor
Wayne State University
Detroit, MI 48207, USA

Dr. Okoli completed his BSN degree in Nursing from the University of Kentucky in 1999. He subsequently completed a Master’s in Public Health and PhD in Nursing from the University of Kentucky in 2005. From 2006-2007 he completed his Postdoctoral training through a Canadian Institute of Health Research (CIHR) funded Strategic Training Program in Tobacco Research (STPTR) administered through the University of Waterloo, Ontario Canada. From 2007 to 2009 he completed a subsequent Postdoctoral Training through the CIHR funded Intersections of Mental Health perspectives in Addictions Research (IMPART) in British Columbia, Canada. He is currently a Clinical Assistant Professor at the University of British Columbia, School of Nursing and an Assistant Professor at the University of Kentucky College of Nursing. Dr Okoli is also an Investigator with the British Columbia Centre of Excellence for Women’s Health. He currently has over 30 peer-reviewed articles in tobacco use addiction and policy.

Tobacco use initiation, dependence, and cessation in special populations (specifically adolescents, and individuals with co-morbid psychiatric disorders and substance use problems), biomarkers of tobacco use and tobacco exposure, health policies related to population-based prevention and control of tobacco use, and sex and gender based analysis of factors associated with tobacco use.

Robert F. Leeman
Associate Research Scientist
Department of Psychiatry
Yale University School of Medicine
New Haven, CT 06519, USA

Richard John Tunney
Associate Professor
University of Nottingham
Nottingham, NG7 2RD, UK

Hans S. Crombag
Associate Professor
School of Psychology
The University of Sussex
UK

Kirsten A. Oinonen
Associate Professor
Director of Clinical Training
Lakehead University
Ontario, Canada

Raymond R. Hyatt
Assistant Professor
Public Health and Community Medicine
Tufts University School of Medicine
Boston, MA 02111, USA

Thomas I. Nathaniel
Assistant Professor
Mary wood University
Pennsylvania, USA

Lora Sabin is an assistant professor at the Center for Global Health and Development and the Department of International Health at Boston University School of Public Health. A health and development economist, Dr. Sabin teaches courses in health economics and research methods. She has also taught extensively in executive education programs in the US (Harvard University, Duke University), China, and Vietnam. Dr. Sabin’s research focuses on applied economics and behavioral issues related to child health and welfare, HIV/AIDS, malaria, and other infectious diseases in Africa, Asia, and Latin America. Current and recent projects include an evaluation of PEFPAR-funded community outreach HIV prevention programs among most-at-risk-populations in Vietnam, a study assessing the effectiveness of an ART adherence intervention in southwestern China, and a cost-effectiveness evaluation of a package of interventions to improve neonatal survival in Zambia. Dr. Sabin holds a PhD in political economy and government from Harvard University

Behavioral issues related to child health and welfare HIV/AIDS Malaria  and other infectious diseases in Africa, Asia and Latin America

Dr. Bruijnzeel is an expert in the neurobiology of drug addiction. He did his graduate studies at the Rudolf Magnus Institute of Neuroscience at Utrecht University in The Netherlands. He received his PhD in Neuropharmacology in 2001. After he completed his graduate studies, he did a 2 year postdoc with Dr. Athina Markou at The Scripps Research Institute in San Diego. In 2004, he joined Department of Psychiatry at the University of Florida as an Assistant Professor. Dr. Bruijnzeel is currently an Associate Professor in the Department of Psychiatry and has a joint appointment in the Department of Neuroscience. He serves on the editorial board of the journal Neuropharmacology and the journal Current Neuropharmacology. Dr. Bruijnzeel has authored about 37 articles in peer reviewed journals and several book chapters.

Investigating the neuronal mechanisms that mediate drug withdrawal and relapse to drug seeking behavior. He has shown that the neuropeptide CRF plays a critical role in the negative mood state associated with nicotine withdrawal and stress-induced relapse to drug seeking behavior.

Robert D. Beech
Assistant Professor
Department of Psychiatry
Yale University
New Haven, CT 06511, USA

Kelly Harmon Webber
Assistant Professor
Department of Nutrition and Food Science
University of Kentucky
Lexington, USA

Assistant Professor
Medicine Division of Pulmonary and Critical Care
Box 980050 Richmond
VA 23298-0050, USA

Pulmonary and Critical Care

Brandon Gaudiano
Assistant Professor
Psychosocial Research
Warren Alpert Medical School of Brown University
Providence, Rhode Island 02906, USA

Marney A. White
Assistant Professor
Department of Psychiatry
Yale University School of Medicine
New Haven, Connecticut, USA

Drake Morgan
Assistant Professor
Department of Psychiatry
University of Florida College of Medicine
Gainesville, FL 32610, USA

Assistant Professor at the Department of Psychiatry at the University of Toronto

Genetics aspects of biobehavioural phenotypes that underlie pathological gambling.

Huiping Zhang
Assistant Professor
Division of Human Genetics
Department of Psychiatry
Yale University School of Medicine
New Haven, USA
 

Dr. Ilana S. Hairston  received his PhD   in Neuroscience at Stanford University  during the period  of 1998-2004.  Currently, she is working as Research Assistant Professor in Psychiatry at the University of Michigan.  She has authored 15 research articles/books, and is a member of the Sleep Research Society, Research Society on Alcoholism, and the Society for Neuroscience.  She has received several honors and awards including a merit award for teaching at Stanford University, and Travel Awards for Excellence in research from the Society of Neuroscience and the Society for Sleep Research

Neural mechanisms underlying sleep regulation, Mechanisms of transdiagnostic symptomatology of sleep disruption in addiction and insomnia, Long-term implications of sleep disruption in trajectory of addiction-related behaviors.

Stacey B. Daughters is currently an Assistant Professor and Director of the Stress, Health, and Addiction Research Program (SHARP) in the Department of Public and Community Health, faculty in the Program in Neuroscience and Cognitive Science, and affiliated faculty in the Clinical Psychology program. Dr. Daughters received her PhD in Clinical Psychology after completing her Clinical Internship in the Brown University Clinical Psychology Training Consortium and Center for Alcohol and Addiction Studies. She As the Director of SHARP. She is the recipient of multiple NIH funded grants, has published over 40 peer reviewerd journal articles and book chapters, and received the 2006 College on Problems of Drug Dependence Early Career Investigator Award, as well as a three year Visiting Professor fellowship from the Center for AIDS Prevention Studies (CAPS) at the University of California, San Francisco.

understanding the interaction of neurobiological and behavioral determinants of stress and addiction, and the translation of this knowledge into effective prevention and intervention programs

Doctor Bränström is a clinical psychologist and he received his PhD in Clinical Cancer Epidemiology in 2003 from the Karolinska Institute, Sweden. Currently he is working as an assistant professor in health psychology and health care sciences at the Karolinska Institute. He is serving as an editorial member of Journal of Addiction Research & Therapy and Journal of Clinical & Experimental Dermatology. He has authored 21 research articles published in international peer-reviewed journals and one book chapter. He is a member of the Society of Behavioral Medicine and the International Society of Behavioral Medicine

Doctor Bränström’s research interests focuses on psychological factors related to cancer, cancer prevention and health promotion behaviors. He has a particular interest in developing new health-risk-reduction programs for families affected by melanoma, and in developing new strategies for communicating cancer risk information to those at risk for developing cancer. He studies strategies to promote behavior changes associated to alcohol and tobacco-related diseases. His current research also involves studies of mindfulness, stress reduction, coping and positive affects, and studies concerning decision making and health behavior.

Hadii M. Mamudu
Assistant Professor of Public Health
Health Services Administration, COPH
TN 37614, USA

Tobacco Use and Control (domestic, regional, and global), Tobacco Control in Developing Countries, the Framework Convention on Tobacco Control, Policy Approaches to Non-communicable Diseases, Public Health Policy (domestic, regional, and global), Policy Analysis, Political Economy, Health Systems Governance and Management, Health and International Trade, Tobacco and Development, Tobacco and Human Rights, Institutionalism, Trans-nationalism, International Organizations and Bureaucracies, Diffusion Studies, and Wellness and Health Promotion.

Carolyn J. Heckman, Ph.D a behavioral researcher, has joined Fox Chase Cancer Centers division of population science as an associate member. Her current focus is a grant from the National Cancer Institute to investigate the use of ultraviolet-filtered photographs showing underlying facial skin damage to encourage skin protection among young adults. Heckman comes to Fox Chase from Massey Cancer Center at Virginia Commonwealth University in Richmond, Va., where she was assistant professor in the departments of psychiatry, psychology and internal medicine. Heckman received her bachelors degree in psychology from Brown University and her Ph.D. in counseling psychology from the University of Iowa, both with honors.She received the Delabarre Award for Outstanding Research/Scholarship in Psychology at Brown University in 1994 and a full Presidential Fellowship from 1996 to 2001 to the University of Iowa. She was also a postdoctoral fellow in health psychology and substance abuse at Virginia Commonwealth University. Heckman is board-certified by the Virginia Board of Psychology. She has written and been invited to speak on a wide range of topics, from tobacco use to excessive tanning as a form of substance dependence. She has been involved in several grant-funded projects, including three from the Tobacco Settlement.

Heckman′s research interests include skin cancer prevention as well as tobacco and other substance-use issues

Scott M. Hyman
Assistant Professor
Carlos Albizu University
Florida, USA

Mari Valle
Assistant Professor
School of Nursing and Health Studies
Northern Illinois University, USA

Yann LE STRAT, MD, is Assistant Professor of Clinical Psychiatry at Louis Mourier Hospital, Colombes, France. Dr. Le Strat received an M.D. from Paris Medical School in 2009 and is a Ph.D. student in Neurosciences. He completed a Clinical and Research Fellowship at the Centre for Addiction and Mental Health (CAMH), Toronto, Canada from 2009 to 2010. He joined Louis Mourier Hospital, Colombes, France, in 2010 and is in charge of the detoxification unit in the psychiatry department. Currently, Dr. Le Strat serves as a reviewer for many scientific journals, as well as for the French National Institute of Health (PHRC program, national funding).

Epidemiology in Mental Health, using large surveys (NESARC, NCS-R).
Genetic epidemiology of addictions and psychiatric disorders.
 

Dr. Christine Courbasson is the Head of the Eating Disorders and Addiction Clinic and serves as Director of Training: Clinical Psychology Practicum Training Program, Centre for Addiction and Mental Health. She holds an appointment of assistant professor with the Department of Psychiatry at the University of Toronto.
She received her Ph.D in Clinical Psychology from York University and was the recipient of a Post-Doctoral Fellowship at the Centre for Addiction and Mental Health. She established the Eating Disorders and Addiction Clinic in 2000 and is involved in the training of clinicians in the application of treatments for concurrent eating disorders and addiction, concurrent anxiety disorders and addiction and other areas of mental health and addiction.  She is the author of a number of articles and book chapters, has lectured on a variety of topics related to her clinical and research interests and has appeared in various television and radio programs.  
 

Eating disorders
Concurrent eating disorders and substance use
Mindfulness and CBT in the treatment of concurrent disorders
 

Neural cell targeting in vivo by synthetic nucleic acids with antisense sequence complementary to mRNA and their use for gene activity detection have advanced our understanding of the molecular mechanisms of stem cell therapy since the discovery of the double-helical DNA in the 1950s. However, cerebral gene activity is rarely done except in biopsy of advanced brain tumor. My most important scholarship in my research career brings molecular biology into living brains: my colleagues and I under my leadership have developed state of the art in vivo gene transcript targeting by magnetic resonance imaging (MRI). I have led several NIH-funded R01 projects where I designed patent-pending MR-visible probes for mRNA and gene transcription factors using targeting MRI technology. Three immediate applications for this technique are (1) evaluation of gene activities after exposure to drug of addiction, (2) neural cell-typing in vivo based on specific gene transcript targeting and (3) brain repair evaluation after cerebral ischemic injury by identify and locate neuroprogenitor cells in vivo.

My research interest is to develop in vivo cell targeting by imaging specific gene transcript or protein in vivo using magnetic resonance image (MRI). Specifically, we plan to use gene targeted MRI to measure changes in deltaFosB and histone deacetylase 5 associated with chronic exposure to amphetamine in live mice. Because mRNA sequence is conserved from rodent to human, the technology can be translated to non-human primates prior to application in humans. My expertise, leadership and motivation necessary to successfully carry out the proposed work are outlined here. I have a broad background in gene targeting technology, with specific training and expertise in research areas. Working as a graduate student under Drs. CC Chang and JE Trosko, I received valuable exposure to the epigenetic theory of carcinogenesis. As a postdoctoral fellow at the University of Washington, Seattle, WA, I intensified my training under Dr. LA Loeb, with whom I learned the mutator theory of cancer and aging. I carried out DNA polymerase purification and gene transfer for the mutator phenotype under a National Research Service Award, and later, a New Investigator Award from NCI. At the Department of Environmental Health Sciences at Case Western Reserve University, Cleveland OH, I taught graduate students (Assistant Professor) and expanded my research as PI of an NSF research grant to include cell cloning of a mutant rodent cell line that under-produces DNA polymerase. I also imaged ongoing DNA repair and quantification of DNA polymerase in cell culture conditions. At the University of Texas, MD Anderson Cancer Center, I worked as Technical Director of the DNA Diagnostic Laboratory. At Baylor College of Medicine, I established myself in neuroscience as PI on an Established Investigator grant funded by the American Heart Association. It was with this project that I laid the groundwork for gene transcript targeting technology, by developing effective antisense strategies in live rodents for gene knockdown, mRNA binding and cell targeting in the living brains of rats.

Tami L. Mark is a Director in the Healthcare & Science Division of Thomson Reuters. She received her PhD in Health Economics from Johns Hopkins University School of Public Health and her B.A from Amherst College. She has published 70 peer reviewed journal articles as well as many government reports and book chapters. Her work has received national and international coverage in the professional and popular press. She is a co-editor of the Datapoints column in the journal Psychiatric Services and has served as a reviewer for more than 25 different journals. She has served on several Substance Abuse and Mental Health Services Administration Technical Advisory Panels.

Prescription medication adoption and utilization patterns Spending and cost of illness analysis Comparative effectiveness using observational data Policies affecting substance abuse service access and quality

Barbara A. Sorg, Professor, received her B.S. in biology in 1981 from Ball State University. In 1987, she earned her Ph.D. in biochemistry from the University of Maryland. Dr. Sorg has been in the Department of Veterinary and Comparative Anatomy, Pharmacology and Physiology at Washington State University since 1990. Dr. Sorg is also the Director of the WSU Alcohol and Drug Abuse Program

Drug addiction, exploring the underlying role of circadian rhythms in relapse.
 

Sandra A. Springer, M.D. is an Assistant Professor of Medicine within the Department of Medicine, Section of Infectious Diseases at Yale School of Medicine. Her primary clinical interest is HIV/AIDS and caring for HIV infected patients at the Veterans Administrative Hospital as Director of the Newington Infectious Disease clinic as well as within the Connecticut State Prisons. Her research interests include improving adherence to antiretrovirals and drug treatment for HIV infected opiate and alcohol dependent men and women. Clinical research includes treating opiate addiction and HIV infection with directly observed buprenorphine in conjunction with antiretroviral therapy as well as using naltrexone as relapse prevention for HIV-infected alcohol dependent prisoners prior to release and continued after release to improve adherence to antiretroviral therapy as well as decrease risk of relapse to alcohol use. She has received a 5 year K23 Career Development Award from NIDA to study adherence interventions for HIV-infected opiate dependent released prisoners providing directly observed antiretroviral therapy and buprenorphine treatment. She has also recently been awarded a 5 year grant from NIAAA as co-P.I. with Frederick Altice, M.D. to evaluate alcohol pharmacotherapies for HIV-infected prisoners.

Improving adherence to antiretrovirals and drug treatment for HIV infected opiate and alcohol dependent men and women
Treating opiate addiction and HIV infection with directly observed buprenorphine in conjunction with antiretroviral therapy

 

Dr. Cheatle earned his PhD in psychology at Princeton University.  He completed his internship at the University of Pennsylvania, School of Medicine.  Currently he is Director of Behavioral Medicine at the PENN Pain Medicine Center and Director, Pain and Chemical Dependency Research at the Center for Studies of Addiction, University of Pennsylvania. Dr. Cheatle specializes in the evaluation and treatment of chronic pain disorders from a biopsychosocial perspective and is currently involved in extensive research in the area of chronic pain and co-occurring mood disorders and substance use disorders.

My interests are in pain and chemical dependency which is a very topical and important issue.

Director, Excelsior Program
Psychiatry and Neurobehavioral Sciences
VA 22908, USA

Psychiatry and Neurobehavioral disorders

Hernan Navarro
Director
Discovery Sciences
RTI International
Research Triangle Park, USA

I am a tenured HEFCE-funded Lecturer in the School of Medicine, University of Southampton. My medical degree was awarded in 1994 and I held clinical appointments until 1997. From 1998 I held an academic appointment and in 2006 I was awarded a PhD for the thesis “Perivascular pathways for the elimination of soluble and particulate matter from the brain: significance for Alzheimer’s Disease and Neuroimmunology”, supervised by Professors Roy O Weller and Hugh V. Perry. The project involved the elucidation of the pathways by which interstitial fluid drains from the brain specifically along the basement membranes of capillary and artery walls. From this work it became clear that it is these pathways that are blocked by Amyloid ß in the elderly and in Alzheimer’s disease. I am familiar with a wide range of techniques including histology, immunocytochemistry, confocal and electron microscopy, biochemical techniques and the BIAcore technique for studying protein binding.

Thiago M. Fidalgo completed his MD at the Federal University of São Paulo, where he also completed his training in Psychiatry. He has been involved in the treatment of addicted patients in the last decade and had his worl recognized by the Health Ministry of Brazil in 2005. In 2010 he completed a
a research fellow at Harvard University, at the Neuromodulation Laboratory.
Currently he is finishing his Mscy Degree and engaging in his PhD. He is responsible for the training of residents at the Drug and Alcohol Unit as well as the Emergency Unit, where he acts as a shift chief, both at Federal University of São Paulo. Moreover, he is the coordinator of the Alcohol Outpatient Cinic at the Cancer’s Hospital – São Paulo, and the chief of an inpatient unit dedicated to the treatment of patients with drug and alcohol addiction. He’s been acting as an editor for some international publications and is the author of books’ chapters and papers on the field.
 

- addiction
- comorbidities
- screening instruments
- emergency psychiatry
- alcohol withdrawn
 

Dr. Newlin received his Ph.D. from Indiana University in 1980.  Currently he works at RTI International, a large nonprofit research company.  He is on the editorial board of three journals in the fields of addictions and man-machine interface.   Dr. Newlin has authored approximately 80 papers or chapters in the addictions and related areas.

Risk for addiction

Experimental psychopharmacology of alcohol and nicotine

Sensitivity to alcohol as a risk factor

Autonomic psychophysiology of craving

Neuroimaging and addiction.

Chief, Molecular Neuropsychiatry Research Branch
NIH/NIDA Intramural Research Program
Baltimore, MD 21224, USA

Research in our section focuses on studies the molecular and cellular mechanisms of stimulant-induced toxicity. Dr. Cadet’s group has provided evidence that methamphetamine (METH) can cause widespread cell death in the rodent brain. These results have stimulated a whole new view of looking at METH-induced neurodegeneration. These results are consistent with the idea that catecholamines, especially, dopamine can activate neurodegenerative processes in the mammalian brain. We have shown that METH can cause activation of cell death related genes, the endoplasmic reticulum stress pathway, and the Fas/FasL death pathway. Recent studies in the laboratory have also shown that METH preconditioning can result in reprogramming of the transcriptional responses to binge administration of the drug. We are presently investigating the possibility that these alterations might be related to drug-induced epigenetic changes in the ventral and dorsal striatum

Michael F. Caldwell
University of Wisconsin – Madison
Madison, Wisconsin, USA

Federico Sanabria
Department of Psychology
Arizona State University
Tempe, AZ, USA

Suzette Glasner-Edwards earned her B.A. in psychology from UCLA and her Ph.D. in psychology at the University of Minnesota. After completing her post-doctoral training at UCSD in the study and practice of psychotherapy for addictions, Dr. Glasner-Edwards worked as the Clinical Director of the Dual Diagnosis program at Cedars-Sinai Medical Center

developing psychosocial interventions and evaluating treatment outcomes for drug abusing adults with concomitant psychopathology, psychological and pharmacological intervention development and outcome evaluation for substance abusers with co-occurring affective disorders

Peter T. Morgan is an Associate Professor of Psychiatry at Yale University, Associate Director, Cocaine Research Clinic and Director, Sleep Research Program of the Clinical Neuroscience Research Unit at Yale.  He completed his psychiatry and addiction psychiatry training at Yale University. He received a PhD in Biomedical Science and the MD from Mount Sinai School of Medicine - New York University, an MS in Engineering and Applied Science from the University of California, Davis, and the BS in Physics from Yale University.

Sleep abnormalities associated with substance dependence, Translational research in cocaine dependence, Learning and Memory

Orion Mowbray
Social Psychology
Eastern Michigan University
Brighton, MI 48116, USA

developing psychosocial interventions and evaluating treatment outcomes for drug abusing adults with concomitant psychopathology, psychological and pharmacological intervention development and outcome evaluation for substance abusers with co-occurring affective disorders

Linkages between substance misuse and violence Facilitating continuing care and 12-step mutual-help group participation Quality of care in substance use and psychiatric disorder treatment Course of treated and untreated substance use disorders and treatment careers Impact of substance misuse and psychiatric disorders on the family

Dr. Cucciare received his PhD in Clinical Psychology from the University of Nevada, Reno in 2006. After completing his clinical internship at the Veteran Affairs Palo Alto Health Care System (VAPAHCS), he completed a two year research fellowship in Health Services Research at the Center for Health Care Evaluation, VAPAHCS and Stanford University School of Medicine. He is currently working as a Research Scientist at the Center for Health Care Evaluation and was recently awarded a five year VA Health Services Research and Development Career Development Award – II. His primary research interest is on using technology to implement evidence-based mental health practices in primary care with an emphasis on brief alcohol interventions. He is currently conducting multiple grant funded studies including a clinical trial to examine the effectiveness of a web-based brief alcohol intervention for reducing heavy drinking in veterans. He has authored numerous peer reviewed articles, chapters, and books.

Implementation of evidence-based mental health practices in medical settings, Computer-based technology and mental health service delivery, Brief interventions for alcohol misuse, Chronic pain, Dementia caregiving.

Committee on the Neurobiology of Addictive Disorders

The Scripps Research Institute

Neurobiology of Addictive Disorders

Rinah Yamamoto
Brain Imaging Center
McLean Hospital
Belmont, MA 02478, USA

Dr. Olsen is currently a Research Instructor at Vanderbilt University School of Medicine in the Department of Molecular Physiology and Biophysics.  He earned his B.A. in Psychology from Baylor University, his M.S. in Biology from Texas Tech University, and his Ph.D. in Neuropharmacology from the University of Texas at Austin.

Addiction, neurobiology of drug and non-drug reward processing, novelty and sensation seeking.

Dr. Wanat is currently working as a senior fellow at the University of Washington in the Department of Psychiatry and Behavioral Sciences studying the role of phasic dopamine transmission during motivated behaviors. He earned his BS studying biochemistry at the University of Wisconsin - Madison in 2002 and received his PhD in neuroscience at the University of California - San Francisco in 2007.  He has been awarded with multiple grants from the National Institute of Drug Abuse.  He has served as a reviewer on numerous respected journals including Biological Psychiatry, International Journal of Developmental Neuroscience, and Current Medicinal Chemistry.

Examining the effect of stress-related neuropeptides and adrenergic agents on phasic dopamine transmission throughout the mesocorticolimbic system in motivated behaviors.

Amelia E. Talley
Department of Psychological Sciences
University of Missouri- Columbia
Columbia, MO 65211, USA

Bhanuprakash Kolla
Department of Psychiatry
Mayo Graduate School of Medicine
NW Rochester, USA

Dr. Jag Khalsa, with 47+ years of experience in drug research, serves as the Chief of the Medical Consequences Branch, NIDA/NIH/DHHS, is responsible for developing/administering a national and international program of clinical research on medical and health consequences of drug abuse and co-occurring infections (HIV, HCV, and others). Prior to joining NIDA in 1987, he served for ~10 yrs as a pharmacologist/toxicologist assessing safety (carcinogenic/teratogenic) potential of chemicals [INDs/NDAs] and food additives) and clinical evaluator at FDA. He has published in pharmacology, toxicology, epidemiology and medical journals. He serves on editorial boards of Journals of Addiction Medicine, Research on HIV/AIDS and Palliative Care, Frontiers of Neuroscience, and Clinical Infectious Diseases. He has received distinguished service awards from the FDA Commissioner, NIDA and NIH Directors, SNIP, Life Time Achievement Awards, a commendation from the US Congress, and ASAM Presidential award. He has a Ph.D. in neuro-psycho-pharmacology, post-doctoral trainings in CNS/Cardiovascular pharmacology at SK&F, and Toxicology at SRI International.

Research programs include metabolic, endocrine and gastrointestinal disorders; pharmacokinetic/pharmacodynamic drug-drug interactions among drugs of abuse, and pharmacotherapeutic agents used in the treatment of infections and drug addiction; dental/oro-maxillary complications; and misuse of prescription drugs.

Michael J. Mancino
University of Arkansas for Medical Sciences
Psychiatric Research Institute
Center for Addiction Research
Arkansas 72205, USA

Monoamine Antagonist Therapies for Methamphetamine Abuse,
Center for Translational Neuroscience,
Stimulant Pharmacotherapy: Noradrenergic Targets,
Cocaine Pharmacotherapies for Comorbid Populations
 

Andrew Percy
School of Sociology
Queens University Belfast
Belfast, Northern Ireland, UK

Gareth Roderique-Davies
Head of Psychology Division
University of Glamorgan, UK